PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
05-Feb-2024 AnaMar Announces US and EU Orphan Drug Designation for AM1476 for Treating Systemic Sclerosis AnaMar
02-Feb-2024 Market Trends and Emerging Technologies in Cartilage Repair Markets and Markets
01-Feb-2024 Maxion Therapeutics Welcomes Dr Arndt Schottelius as New CEO Maxion Therapeutics
01-Feb-2024 NeoPhore raises an additional £9.6m (USD $12.2m) Series B financing extension to further progress drug discovery pipeline NeoPhore Limited
01-Feb-2024 EnteroBiotix Strengthens its Executive Team, Appoints COO and CFO EnteroBiotix
01-Feb-2024 NICE publishes guidance in England & Wales recommending Zynlonta® (loncastuximab tesirine) as an additional option for adults with relapsed or refractory diffuse large B-cell lymphoma or high-grade B-cell lymphoma Sobi
01-Feb-2024 Maxion Therapeutics Welcomes Dr Arndt Schottelius as New CEO Maxion Therapeutics
31-Jan-2024 OKYO Pharma Announces Distinguished Ophthalmologists with Expertise in the Medical and Surgical Treatment of Ocular Surface Diseases Join its Scientific Advisory Board OKYO Pharma Limited
31-Jan-2024 Green Elephant Biotech launches the world's first plant-based 96-well plate, for laboratory sustainability Green Elephant Biotech GmbH
31-Jan-2024 Almirall and Microsoft announce partnership for digital transformation to enable the development of novel treatments for skin diseases Almirall
31-Jan-2024 Microbiome research supports use of Steriwave SPIE Photonics West
31-Jan-2024 AAVantgarde appoints Nina (Ekaterini) Kotsopoulou, Ph.D., as Chief Technical Officer AAVantgarde Bio
31-Jan-2024 MetrioPharm Publishes First Trial Data Showing Effects of Host-Directed Therapy in COVID-19 MetrioPharm
30-Jan-2024 PHARMANOVIA APPOINTS NEW REGIONAL MANAGER – SPAIN, PORTUGAL AND FRANCE Pharmanovia
30-Jan-2024 Huxley Health Inc. Provides Corporate Update - Appoints Bruce Linton as Chairman Huxley Health Inc
30-Jan-2024 ABPI welcomes Labour's life sciences plan ABPI
30-Jan-2024 Fabentech awarded €7.7m from the European Commission as coordinator of the e FabRIC consortium to develop an innovative broad-spectrum therapy against emerging viruses with pandemic potential Fabentech
30-Jan-2024 Axplora invests €8 million in Le Mans to further expand its capacity for antibody drug conjugate manufacturing Axplora
30-Jan-2024 OPEN X Health launches to provide data-driven creativity to the pharmaceutical industry OPEN X Health
30-Jan-2024 HUTCHMED Receives ELUNATE® (fruquintinib) Marketing Approval in Hong Kong for Treatment of Metastatic Colorectal Cancer HUTCHMED